Avanos Medical to Host Conference Call for Q2 Financials

Author: Dylan Bailey Updated: 07-24-2025 10:25 AM

Avanos Medical to Host Q2 Financial Results Conference Call

Avanos Medical, Inc. (NYSE: AVNS) is preparing to host a conference call to discuss its financial results and strategic business highlights for the second quarter of 2025. This informative session is scheduled for an upcoming Tuesday morning. The call aims to provide stakeholders with a comprehensive overview of the company's recent performance and future outlook.

What to Expect During the Call

The conference call will be conducted by key executives: Dave Pacitti, the chief executive officer; Jason Pickett, interim chief financial officer; and Scott Galovan, senior vice president of strategy and corporate development. Their insights will likely focus on the company's achievements, financial metrics, and initiatives aimed at enhancing patient outcomes.

Joining the Call

To participate in the call, interested individuals can easily register through an online link that will be provided shortly before the call starts. This convenient option will initiate a system call that connects attendees directly to the conference. Alternatively, attendees can dial a dedicated number to join the discussion directly with an operator.

Webcast and Replay Access

The call will also feature a live webcast that can be accessed via the Investors section of the Avanos Medical website. Following the live discussion, a replay will be made available. This will allow those who could not attend the call to catch up on the critical information shared regarding the company's performance.

About Avanos Medical, Inc.

Avanos Medical, Inc. is a leading medical technology company committed to providing innovative solutions in healthcare. The company focuses on producing clinically advanced medical devices aimed at helping patients regain their quality of life. Their strategic efforts include improving patient nutrition from hospital to home and reducing opioid dependency during recovery periods.

With headquarters situated in Alpharetta, Avanos operates globally, maintaining its dedication to addressing important healthcare challenges. The company is recognized for its various product lines that cater to diverse medical needs, and it continues to hold strong positions across multiple market categories. To learn more, visit their official website and follow them on social media platforms like X, LinkedIn, and Facebook.

Frequently Asked Questions

When will Avanos Medical host the conference call?

The conference call is scheduled for an upcoming Tuesday, with details available shortly before.

Who will be speaking on the call?

Key executives including Dave Pacitti, Jason Pickett, and Scott Galovan will be leading the discussion.

How can I join the conference call?

Participants can register for the call online or join via dedicated phone numbers provided for direct access.

Will the conference call be available for replays?

Yes, a replay of the call will be available shortly after it concludes, allowing for convenient access.

What is Avanos Medical's focus?

Avanos Medical is committed to providing leading medical device solutions aimed at improving patient outcomes and addressing essential healthcare needs.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.